News brief
On 2026-07-13, according to Xiniu Data, Yaowumuchang completed Series D financing, raising USD 55 million. Investors were lead investor Pudong Venture Capital Group, participating investor Zhikai Capital, participating investor Shenzhen City Luohudonghairuizhi Pharmaceutical Industrial Investment Partnership (Limited Partnership), participating investor Keyuanzhiyao, participating investor Baiaoweida, participating investor YD Capital, participating investor Jiashanguotou, participating investor Detong Capital, participating investor Weidu Capital, participating investor Biometas. The company is a novel drug developer.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年7月13日，据烯牛数据报道，药物牧场完成D轮融资，金额5500万美元。投资方为浦东创投集团领投，致凯资本、深圳市罗湖东海睿智医药产业投资合伙企业（有限合伙）、科源制药、百奥维达、YD Capital、嘉善国投、德同资本、苇渡资本、Biometas跟投。该公司为原创新药研发商。